MoMs Hips a Grinding Dilemma for Hospitals, Doctors, FDA
During the two days, panel members heard a mind-boggling array of words and phrases to describe the damage to bone, tissue, and blood resulting from MoM devices:
Tribocorrosion, trunnions, fracture of resurfacing systems, edge wear, microseparation, pseudotumors and asceptic lymphocytic vasculiis-associated lesions, voltage effects, infections, post-operative nerve palsy, prosthesis loosening, implant breakage or fracture, femoral neck fractures and heterotopic ossification, loss of mobility and pain, and mechanically assisted corrosion, to name just a few.
Starting a decade ago, newer MoM devices were seen as a safer alternative to prostheses made of polyethylene or ceramic, which wore out faster, and which released particles that could accumulate in local tissue and erode the bone.
Metal devices, which would last longer, held a promise to solve that problem, because they were seen as more appropriate for younger people who wanted to remain active in their 60s and 70s and beyond without having to undergo a revision surgery.
- Senators Hear How Two-Midnight Rule Harms Patients, Hospitals
- 3 Management Lessons from a Supermarket Debacle
- Medicare Advantage Carriers See 'No Choice' But to Accept Cuts
- Physicians to Appeal 'Docs v. Glocks' Ruling in FL
- IOM Identifies GME Problems, Calls for Finance Changes
- Healthcare Costs Start With What We Eat
- Revenue Cycles Get a Boost from Simple JPEG Files
- Handshaking Spreads Germs. Get Over It.
- Hospitals Likely to Outsource ICD-10 at Launch
- CA Fines 8 Hospitals for Medical Errors